Cardiovascular disease stands as the leading cause of death for both men and women in the United States, responsible for 33% of all fatalities and surpassing the death toll from all cancer types combined.

The American Heart Association highlights a concerning statistic: 50% of men and 64% of women who die suddenly from coronary vascular disease exhibit no prior symptoms. Moreover, up to 50% of individuals who succumb to heart attacks or strokes possess "normal" lipid profiles according to standard health evaluations. These facts underscore the necessity of the CIMT test as a critical tool for early detection and intervention in cardiovascular health.